JSP191-Based Conditioning
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 40 patients (estimated)
- Sponsors
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Monoclonal Antibody
- Trial Type
- Treatment
- Last Update
- 3 weeks ago
- SparkCures ID
- 1734
- NCT Identifier
- NCT05907746
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.